Seroprevalence and Determinants of SARS-CoV-2 Antibodies Among Healthcare Workers in Dar es Salaam, Tanzania
Studies from the Sub-Saharan African (SSA) countries suggest an underestimate of SARS-CoV-2 infections during the pandemic. We investigated the seroprevalence and factors associated with anti-SARS CoV-2 seropositivity among healthcare workers (HCWs) in Dar es Salaam, Tanzania. We conducted a cross-sectional study in three tertiary hospitals in Dar es Salaam among randomly selected HCWs between October 2021 and March 2022. Demographic and SARS-CoV-2-related exposures were collected as well as blood for Immunoglobulin G (IgG) against SARS-CoV-2 nucleocapsid (IgG-N) or spike (IgG-S) proteins using WHO/FDA-pre-qualified SARS-CoV-2 ELISA test kits. Descriptive statistics were used to determine the SARS-CoV-2 antibody prevalence. Multivariable Modified Poisson regression was used to determine the association between HCWs characteristics and SARS-CoV-2 serologic status. Of the 394 participants [mean age (SD) of 37.9 (9.8) years] included, 327 (83%) had never been tested for COVID-19 before the study and 148 (37.6%) had received at least one dose vaccine against COVID-19 at enrolment. The overall seroprevalence of SARS-CoV-2 IgG (including IgG-N, IgG-S or both) was 90.9% (95% CI: 76.7–96.8%). HCWs who had at least one dose of vaccine against COVID-19 were 13% more likely to be seropositive than those who were not vaccinated (aPR = 1.13 (95% CI: 1.02–1.25; p = 0.023). HCWs who believed they had COVID-19 but never tested had 9% higher seroprevalence compared to those who believed they never had COVID-19 (aPR = 1.09; 95% CI: 1.03–1.16; p = 0.003). HCWs working in the laboratory, anesthesia and obstetrics and gynecology departments were more likely to have SARS-CoV-2 antibodies than HCWs from the emergency medicine department (EMD). The seroprevalence of anti-SARS-CoV-2 IgG among HCWs in this study was high despite low vaccine coverage in this population indicating high SARS-CoV-2 exposure among HCWs. Our work highlights the need for more effective infection control practices in healthcare settings in future pandemics like these, especially among HCWs at highest risk.
Authors
- Erick Alexander Mboya (ORCID: https://orcid.org/0000-0002-3279-6256)
- Grace Ambrose Shayo (ORCID: https://orcid.org/0000-0001-9482-8703)
- Tumaini Joseph Nagu (ORCID: https://orcid.org/0000-0001-8529-2804)
- Faraja Simon Chiwanga (ORCID: https://orcid.org/0000-0003-0033-568X)
- Claudia Hawkins (ORCID: https://orcid.org/0000-0001-7228-6317)
- Mangaro Mabusi
- Said Aboud (ORCID: https://orcid.org/0000-0003-0981-3350)
- Raphael Zozimus Sangeda (ORCID: https://orcid.org/0000-0002-6574-5308)
- Davis Elias Amani (ORCID: https://orcid.org/0000-0003-0563-8188)
- Sabina Ferdinand Mugusi (ORCID: https://orcid.org/0000-0003-3367-0564)
- Joan Rugemalila (ORCID: https://orcid.org/0000-0001-6939-5125)
- Ferdinand M Mugusi (ORCID: https://orcid.org/0000-0001-7479-4913)
- Doreen Kamori (ORCID: https://orcid.org/0000-0001-5162-6554)
- Muhammad Bakari (ORCID: https://orcid.org/0009-0004-3914-1676)
- Upendo Nkwera
Institutions
- Northwestern University (US)
- Muhimbili University of Health and Allied Sciences (TZ)
- Muhimbili National Hospital (TZ)
- National Institute for Medical Research (TZ)
Publication Details
- Journal
- COVID
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/covid6110205
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Northwestern University
- Muhimbili University of Health and Allied Sciences
- University of Health and Allied Sciences